Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study.
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Inadequate antimicrobial treatment is an independent determinant of hospital mortality, and fungal bloodstream infections are among the types of infection with the highest rates of inappropriate initial treatment. Because of significant potential for reducing high mortality rates, we sought to assess the impact of delayed treatment across multiple study sites. The goals our analyses were to establish the frequency and duration of delayed antifungal treatment and to evaluate the relationship between treatment delay and mortality. METHODS: We conducted a retrospective cohort study of patients with candidemia from 4 medical centers who were prescribed fluconazole. Time to initiation of fluconazole therapy was calculated by subtracting the date on which fluconazole therapy was initiated from the culture date of the first blood sample positive for yeast. RESULTS: A total of 230 patients (51% male; mean age +/- standard deviation, 56 +/- 17 years) were identified; 192 of these had not been given prior treatment with fluconazole. Patients most commonly had nonsurgical hospital admission (162 patients [70%]) with a central line catheter (193 [84%]), diabetes (68 [30%]), or cancer (54 [24%]). Candida species causing infection included Candida albicans (129 patients [56%]), Candida glabrata (38 [16%]), Candida parapsilosis (25 [11%]), or Candida tropicalis (15 [7%]). The number of days to the initiation of antifungal treatment was 0 (92 patients [40%]), 1 (38 [17%]), 2 (33 [14%]) or > or = 3 (29 [12%]). Mortality rates were lowest for patients who began therapy on day 0 (14 patients [15%]) followed by patients who began on day 1 (9 [24%]), day 2 (12 [37%]), or day > or = 3 (12 [41%]) (P = .0009 for trend). Multivariate logistic regression was used to calculate independent predictors of mortality, which include increased time until fluconazole initiation (odds ratio, 1.42; P < .05) and Acute Physiology and Chronic Health Evaluation II score (1-point increments; odds ratio, 1.13; P < .05). CONCLUSION: A delay in the initiation of fluconazole therapy in hospitalized patients with candidemia significantly impacted mortality. New methods to avoid delays in appropriate antifungal therapy, such as rapid diagnostic tests or identification of unique risk factors, are needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The mortality reduction associated with early antimicrobials appears strongest in patients with septic shock, where studies have reported a strong association between time to antibiotics and death in patients with septic shock but weaker associations in patients without septic shock (98,109,110).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [109]
In the citing paper
“Blood cultures take an average of 2–3 days to grow Candida, or longer depending on the species.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [135]
In the citing paper
“Attributable mortality from IC remains high and increases with delays in treatment.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [135]
In the citing paper
“Some observational studies suggested that prompt initiation of appropriate empiric antifungal therapy may be associated with a reduction in mortality, however these studies do not prove a causal relationship between antifungal therapy and outcome, nor do they clarify the role of timing of treatment, and some other studies have failed to show this association [167, 171–173].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [171]
In the citing paper
“Multivariate analysis in this study also provided a strong association between delay in therapy and mortality.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [46]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 11×
“By contrast, gram-positive bacteria, such as coagulase-negative staphylococci, S. aureus, and Enterococcus species, account for 60% of all BSIs [16].”
BackgroundInfluentialIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 2×
“of inappropriate initial treatment [6].”
BackgroundMorrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286 · cited 5×
“Delaying antifungal therapy appears to be a common practice, and the impact on mortality may be significant [8, 10].”
BackgroundResultInfluentialAttributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140 · cited 2×
“Attributable mortality rates of 49% were also shown among patients with candidemia, compared with uninfected control subjects matched for age, sex, date of hospital admission, underlying diseases, length of time at risk, and type of surgical procedure [5].”
BackgroundPfaller, M. A., Diekema, D. J., Jones, R. N., Sader, H. S., Fluit, A. C., Hollis, R. J., Messer, S. A., & The SENTRY Participant Group (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3254-3259.2001 · Cited by 521 · cited 1×
“[1].”
Morgan, J., Meltzer, M. I., Plikaytis, B. D., Sofair, A. N., Huie-White, S., Wilcox, S., Harrison, L. H., Seaberg, E. C., Hajjeh, R. A., & Teutsch, S. M. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502581 · Cited by 437 · cited 2×
“attributable mortality remains 19%–49% [2, 5].”
Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00240-x · Cited by 331 · cited 10×
“By contrast, gram-positive bacteria, such as coagulase-negative staphylococci, S. aureus, and Enterococcus species, account for 60% of all BSIs [16].”
BackgroundInfluentialThe Impact of Candidemia on Length of Hospital Stay, Outcome, and Overall Cost of Illness
Rentz, A. M., Halpern, M. T., & Bowden, R. (1998) · Clinical Infectious Diseases · doi:10.1086/514955 · Cited by 310 · cited 1×
“of 8 cases per 100,000 population [2–4].”
Leinberger, D. M., Schumacher, U., Autenrieth, I. B., & Bachmann, T. T. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.4943-4953.2005 · Cited by 155 · cited 1×
“Development of nonculture methods for the rapid diagnosis of candidemia in patients with BSI may also significantly improve the ability to quickly prescribe appropriate antifungal therapy [19, 20].”
Epidemiology and Prognostic Determinants of Bloodstream Infections in Surgical Intensive Care
Harbarth, S. (2002) · Archives of Surgery · doi:10.1001/archsurg.137.12.1353 · Cited by 135
Cited by
Items 901–1,000 of 1,000
Fungal and Parasitic Infections
Mattiuzzi, G. N., & Ostrosky-Zeichner, L. L. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-415-5_4 · Cited by 3
“Since research has shown that early treatment has a definite impact on patient outcomes [2, 3], contemporary management strategies go well beyond treatment of full-blown disease.”
BackgroundCandidemia and non-candidemia related septic shock: are there differences between them?
Kollef, M. H., Paiva, J.-A., & Charles, P. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3332-6 · Cited by 4
“, \40 %) are already receiving antifungal agents before blood culture positivity is known [2–4].”
Jansoniene, O., & White, M. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1612ed · Cited by 3
Die Therapie der schweren Sepsis
Lorenz, J. (2009) · Pneumologie · doi:10.1055/s-0028-1119702 · Cited by 4
Honoré, P. M., Redant, S., Préseau, T., Moorthamers, S., Kaefer, K. M., Gutierrez, L. B., Attou, R., Gallerani, A., & Bels, D. D. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1964954 · Cited by 3
An update on antimicrobial selection and duration for intra-abdominal infections
Lee, Y.-L., & Hsueh, P. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2580451 · Cited by 2
“Early initiation of antifungal therapy has been associated with improved survival, particularly when initiated before or concurrently with source control procedures [52].”
Badrane, H., Clancy, C. J., & Nguyen, M. H. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01545-25 · Cited by 2
Lok, B., Lau, N., Miswan, N., Shu‐Chien, A. C., Shahpudin, S. N. M., Zhang, H.-L., & Sandai, D. A. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108311 · Cited by 2
Albakri, S., Aljabri, A., Alharbi, E. A., Alammash, B. B., Alabdali, S. A., Alahmadi, M., Almutairi, N. M., Alharbi, H., Alzahrani, F., & Alnezary, F. S. (2026) · Infection and Drug Resistance · doi:10.2147/idr.s579631 · Cited by 2
“10,23,24 There remains a significant knowledge gap regarding the real-world effectiveness and safety of EAFT strategies in Middle Eastern ICU settings, where differences in local epidemiology, resistance patterns, and patient comorbidities may influence outcomes.”
InfluentialMortality of Candidozyma auris Candidemia Compared with Non-C. auris Candidemia
Park, S., Kim, H., Hwang, K., Hong, D., & Oh, H.-Y. (2026) · Journal of Fungi · doi:10.3390/jof12040234 · Cited by 2
“Early antifungal therapy was defined as initiation of an antifungal agent within 24 h of the first positive blood culture [15], whereas appropriate antifungal therapy was defined as administration of an antifungal agent in accordance with antifungal susceptibility results.”
Moulds: diagnosis and treatment
Verweij, P. E., & Maertens, J. A. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp080 · Cited by 2
Epidemiología de la candidemia en el Hospital México
Vindas, J. V., Cordero, J. A. C., Montoya, A. A. A., Gil, M. C. P., Somogyi, T., & Sandoval, L. (2020) · Acta Médica Costarricense · doi:10.51481/amc.v58i1.908 · Cited by 4
Indication des traitements antifongiques (hors hématologie). Que montrent les données ?
Huette, P., & Dupont, H. (2019) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2019.03.004 · Cited by 2
Wani, A. R., Kumar, L., Singhal, R., Chakraborti, A., & Khot, S. M. (2021) · Tropical Doctor · doi:10.1177/00494755211054696 · Cited by 2
“Delays thus caused, are associated with increased rates of mortality.(2) Fungal colonisation in TB patients is estimated at between 15–32%.”
BackgroundCandidemia in Older Adults: What Are the Risk Factors for Mortality?
Taşar, P. T., Karaşahin, Ö., Karahan, B., Kızıltunç, H. S., & Albayrak, A. (2022) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.20229809 · Cited by 2
Marx, A. H., Cluck, D. B., Green, S. B., Anderson, D. T., Stover, K. R., Chastain, D. B., Covington, E. W., Jones, B. M., Lantz, E., Rausch, E. P., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac600 · Cited by 2
Benefits of early antifungal therapy in hematology patients
Andreev, S. S., Бронин, Г. О., Epifanova, N. Y., Kozlova, O. P., Пристанскова, Е. А., Khostelidi, S. N., & Витальевна, Ш. О. (2024) · Oncohematology · doi:10.17650/1818-8346-2024-19-1-99-112 · Cited by 2
Posaconazole and Its Pharmacologic and clinical Uses: An Antifungal Drugs
Alghamdi, S. A., & Asif, M. (2022) · Journal of Biological Studies · doi:10.62400/jbs.v5i2.6187 · Cited by 3
Ikeda, K., Ifuku, T., Matsumoto, Y., Haraguchi, M., Fukumoto, Y., & Tsuchiya, K. (2024) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2024.08.022 · Cited by 2
Candidemia Surveillance and Impact on Non-neutropenic Critically Ill Patients
Zimmerman, L. H., Dolman, H. S., Faris, J. J., Park, L., Mynatt, R. P., Zimmerman, W. B., Baylor, A. E., Tyburski, J. G., & Wilson, R. F. (2024) · Cureus · doi:10.7759/cureus.73155 · Cited by 2
Laderas, J. C. P. (2009) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(09)70012-9 · Cited by 2
Carrillo-Dover, P., Álvarez-Vega, C., Salas-Campos, I., & Mora-Brenes, N. (2009) · Acta Médica Costarricense · doi:10.51481/amc.v51i3.443 · Cited by 7
Treatment of candidemia with echinocandins: data on hospital resource use from a real world setting
Wade, R. L., Chaudhari, P., Campbell, R. S., Hays, H. D., Nathanson, B. H., Yi, J., & Horn, D. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.708690 · Cited by 2
Stratégies thérapeutiques en réanimation
Eggimann, P. (2007) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(07)80052-7 · Cited by 2
Evaluation of a Positive Yeast-in-Blood Service
Stover, K. R., Cleary, J. D., & Nolan, R. L. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000193 · Cited by 2
“05).(5) Investigators at Washington University confirmed the relationship between mortality and timing of antifungal therapy.”
BackgroundMethodInfluentialInvasive Candidiasis and the Utility of Antifungal Susceptibility Testing in the ICU
Coyle, E. A. (2010) · Journal of Pharmacy Practice · doi:10.1177/0897190009356552 · Cited by 2
Complications of sepsis: the role of risk prediction rules, biomarkers and host genetics
Haeusler, G. M., & Slavin, M. A. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.56 · Cited by 2
Zaragoza, R., Llinares, P., Maseda, E., Ferrer, R., & Rodríguez, A. H. (2013) · Revista Española de Anestesiología y Reanimación · doi:10.1016/j.redar.2013.05.016 · Cited by 3
RNAi technology: A Novel approaches against fungal infections
Moazeni, M., Nabili, M., Badali, H., & Abastabar, M. (2014) · Research in Molecular Medicine · doi:10.18869/acadpub.rmm.2.3.1 · Cited by 3
“In large scale, matching the patient and fungal disease with an antifungal regimen as well as delayed initiation of antifungal treatment would affect IFI management (8-10).”
BackgroundIn vitro evaluation of vincristine and fluconazole combination against Candida.
Khan, A. A., Khurshid, M., & Tawfik, A. F. (2013) · PubMed · Cited by 3
Factors influencing recovery in patients with hemoblastoses and candidemia
Klyasova, G. A., Блохина, Е. В., Gracheva, A., Кравченко, С. К., Parovichnikova, E. N., Александрович, О. В., Korobova, A. G., Galstyan, G. M., & Kulikov, S. M. (2015) · Terapevticheskii arkhiv · doi:10.17116/terarkh201587777-87 · Cited by 2
“из гемокультуры, и 41% — при назначении на 3-й день и позже (p=0,0009) [24].”
State of the Art in the Laboratory Methods for the Diagnosis of Invasive Fungal Diseases
Quindós, G., Eraso, E., Ezpeleta, G., Pemán, J., & Sánchez, F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411629-0.00017-9 · Cited by 3
Budding Yeast Cells in Peripheral Blood Smear: Clue to Candidemia
Cho, S., Chae, H., Kim, M., Lee, D., & Kim, H. (2016) · Infection and Chemotherapy · doi:10.3947/ic.2016.48.4.342 · Cited by 2
“Rapid diagnosis and appropriate antifungal treatment significantly impact a prognosis of candidemia, especially in immunocompromised patients [1].”
BackgroundGonzález-Lara, M. F., Torres‐González, P., Rangel‐Cordero, A., Sifuentes‐Osornio, J., Ponce‐de‐León, A., & Martínez‐Gamboa, A. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.07.004 · Cited by 2
Bilal, H. M. (2017) · Archives of Cancer Science and Therapy · doi:10.29328/journal.acst.1001003 · Cited by 3
Seal, P., & Pappas, P. G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-4064-1.00060-9 · Cited by 2
Yoo, J. R., Shin, B. R., Jo, S., & Heo, S. T. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2019.259 · Cited by 3
Epidemiology, Risk Factors and Mortality of Candidemia: Case-control Study
Özdemir, K., Kocaoğlu, C., Kutlu, S. S., Ergin, Ç., & Kutlu, M. (2020) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.68736 · Cited by 4
“Therefore, in the management of candidemia, it is important to initiate treatment empirically in the early period with an appropriate antifungal agent[13-16].”
BackgroundOkuno, D., Oshima, K., Miyazaki, T., Ashizawa, N., Hirayama, T., Takazono, T., Saijo, T., Yamamoto, K., Imamura, Y., Yamaguchi, H., et al. (2020) · Clinical Case Reports · doi:10.1002/ccr3.3628 · Cited by 2
Evaluation of Chitin as a Biomarker of Pathogenic Fungal Isolates
Lafi, A. S. A., Santhanam, J., Khaithir, T. M. N., Musa, N. F., & Huyop, F. (2021) · Sains Malaysiana · doi:10.17576/jsm-2021-5003-15 · Cited by 2
“Early diagnosis together with correct antifungal treatments contributes to the favorable prognosis of patients with invasive fungal infections (IFI) (Garey et al. 2006).”
BackgroundБонда, Н. А., Tapalski, D. V., & Стома, И. О. (2021) · Infectious diseases News Opinions Training · doi:10.33029/2305-3496-2021-10-2-54-59 · Cited by 2
Fungaemia and disseminated infection
Lester, R., & Rex, J. H. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198755388.003.0025 · Cited by 2
Hamilton, D. O., Lambe, T., Howard, A., Crossey, P., Hughes, J., Duarte, R. V., & Welters, I. D. (2022) · Medical Mycology · doi:10.1093/mmy/myac034 · Cited by 2
Spontaneous Fungal Peritonitis in Egyptian Patients with Cirrhotic Ascites
Gohar, N. M., Sarei, R. A., Marzouk, H., & El-Beshlawy, M. (2019) · The Egyptian Journal of Medical Microbiology · doi:10.21608/ejmm.2019.282429 · Cited by 2
“56% of the studied patients were Child-Pugh class B, 44% were Child-Pugh class C, while none was Child-Pugh class A and MELD score ranging from (6-35).”
BackgroundThe Impact of Antifungal Drug Resistance in the Clinic
Lewis, R. E., & Kontoyiannis, D. P. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch23 · Cited by 2
Clinical application of antifungal pharmacodynamics
Gallagher, J. C. (2009) · Current Fungal Infection Reports · doi:10.1007/s12281-009-0010-1 · Cited by 2
Fekete, T. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-2-200807150-00011 · Cited by 2
“With rigorous infection control practices, careful management of long-term vascular catheters, and early effective treatment of suspected or documented fungemia in select high-risk patients (7), we simply do not need prophylaxis, which is a blunt tool at best.”
BackgroundErratum to: An Italian consensus for invasive candidiasis management (ITALIC)
Scudeller, L., Viscoli, C., Menichetti, F., Bono, V. D., Cristini, F., Tascini, C., Bassetti, M., & Viale, P. (2014) · Infection · doi:10.1007/s15010-013-0577-x · Cited by 2
Transcriptional Regulation of Azole Antifungal Resistance and Tolerance in Candida Glabrata
Caudle, K. E. (2010) · doi:10.21007/etd.cghs.2010.0045 · Cited by 4
“Early diagnosis and species identification leads to earlier initiation of optimal treatment which has been shown to improve clinical outcome (69).”
BackgroundEchinocandine bei invasiven Candida-Infektionen
Glöckner, A., & Cornely, O. A. (2008) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-008-1058-3 · Cited by 2
“Die Prognose einer Candidämie wird in wesentlichem Maße vom frühzeitigen Beginn einer wirksamen antimykotischen Therapie beeinflusst [6, 7].”
BackgroundBordallo-Cardona, M. Á., Sánchez‐Carrillo, C., Muñóz, P., Bouza, E., Escribano, P., & Guinea, J. (2019) · Medical Mycology · doi:10.1093/mmy/myy155 · Cited by 2
van Zanten, A. R. H. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318258e7f3 · Cited by 2
Invasive Candidiasis in the Intensive Care Unit
Krishnan, S., & Ostrosky-Zeichner, L. L. (2010) · Hospital Practice · doi:10.3810/hp.2010.04.298 · Cited by 2
„Tarragona-Strategie“: Adäquate Antibiotikatherapie auf der Intensivstation
Engelmann, L., & Schmitt, D. V. (2014) · Wiener klinisches Magazin · doi:10.1007/s00740-014-0027-0 · Cited by 3
Yılmaz, K., Demiray, T., Köroğlu, M., Hatipoğlu, H., Kılıç, Ü., Karabay, O., & Altındiş, M. (2020) · Mediterranean Journal of Infection Microbes and Antimicrobials · doi:10.4274/mjima.galenos.2019.2019.37 · Cited by 1
New Tools in Laboratory Diagnosis of Invasive Fungal Infections
Martínez‐Gamboa, R. A. (2022) · Fungal biology · doi:10.1007/978-3-030-89664-5_15 · Cited by 1
ÖNDER, K. D., & Keskin, A. S. (2023) · Cureus · doi:10.7759/cureus.35071 · Cited by 1
“also indicated that delayed initiation of AF therapy is associated with mortality [19].”
BackgroundDiagnostics of Candida and Candidiasis: Current Methods and Future Perspectives
Banik, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-4909-6_1 · Cited by 2
Permpalung, N., Uhteg, K., Rodrigues, M. M. D. S., Memon, W., Totten, M., & Zhang, S. X. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.05.022 · Cited by 1
Miaux, G., Benkhelil, R., Dewulf, G., Loridant, S., Dannaoui, É., & Mazars, E. (2025) · Medical Mycology · doi:10.1093/mmy/myaf077 · Cited by 1
Khamrai, A., Reddy, S., Paul, S., Saroya, A., Verma, S., Bhangot, D., Rudramurthy, S. M., Kaur, H., Taneja, N., & Ghosh, A. K. (2025) · Mycopathologia · doi:10.1007/s11046-025-00987-x · Cited by 1
“The direct method’s ability to reduce turnaround time by at least 24 h has significant clinical implications, allowing earlier antifungal therapy adjustments, which is crucial given that delayed treatment is associated with increased mortality in candidemia [38].”
Borges, J. C. E., Siqueira, L. P. M., de Freitas, V. L. T., de Oliveira, V. F., Magri, A. S. G. K., da Silva, A. R., de Araújo, E. D. M. P. A., Cury, A. P., & Magri, M. M. C. (2025) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946202567064 · Cited by 1
Stewart, A. G., Douglas, A. P., Kidd, S. E., Salmanton-Garcia, J., Cornely, O. A., Morris, A. S., Halliday, C. L., & Chen, S. C. ‐. (2026) · Pathology · doi:10.1016/j.pathol.2025.09.012 · Cited by 1
Nehemia, M., Cohen, H., Gruzman, O., Amador, T. M. V., Levy, S. B., Grisaru‐Granovsky, S., & Menachem-Zidon, O. B. (2026) · Biomedicines · doi:10.3390/biomedicines14050994 · Cited by 1
Development of Machine Learning Models to Predict Candidemia in Hospitalized Adult Patients
Hashimoto, K., MATSUMOTO, K., & Murotani, K. (2025) · The Kurume Medical Journal · doi:10.2739/kurumemedj.ms721234017 · Cited by 1
From Oral Candidiasis to Candidemia: A Review of Superficial to Invasive Progression
Jerez, J. R., Ambrosio, M. V., Fernandes, M. E. O., & Mima, E. G. D. O. (2026) · MicrobiologyOpen · doi:10.1002/mbo3.70353 · Cited by 1
“In this context, a retrospective cohort study of patients with candidemia observed that the timing of fluconazole therapy initiation in hospitalized patients with candidemia had a significant impact on mortality (Garey et al. 2006).”
Colombo, A. L., Magri, M. M. C., Carlesse, F. A. D. M. C., Falci, D. R., Garnica, M., Santos, D. W. D. C. L., Queiroz‐Telles, F., & Pasqualotto, A. C. (2026) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2026.105946 · Cited by 2
“88,89 This creates a dilemma: starting empirical therapy too broadly increases unnecessary drug exposure, resistance selection, and costs, while delaying treatment in true cases of candidemia worsens outcomes.”
Traboulsi, R. S. (2009) · CRC Press eBooks · doi:10.3109/9780849387869-17 · Cited by 1
Utilizing Rapid Diagnostics for Detection of Candida Species
Brady, A. C., Wong, B., & Pfeiffer, C. D. (2015) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-015-0049-1 · Cited by 1
Glöckner, A., & Cornely, O. A. (2013) · Der Anaesthesist · doi:10.1007/s00101-013-2208-4 · Cited by 2
Norkin, M. N., & John, R. (2011) · InTech eBooks · doi:10.5772/22537 · Cited by 1
“Among numerous potential pathogens Candida and Aspergillus spp. are the major causative fungi leading to life-threatening infectious complications in AL and HCT recipients [4]. www.intechopen.com Stem Cells in Clinic and Research 658 Invasive Candidasis Candida fungemia and invasive Candidasis (IC) often occur during…”
BackgroundInfluentialBougnoux, M., Lacroix, C., Hassouni, N., Béretti, J., & Dauphin, B. (2011) · Bio Tribune Magazine · doi:10.1007/s11834-011-0064-6 · Cited by 1
Canbay, A. E., & Glöckner, A. (2013) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-013-0262-y · Cited by 1
Invasive Fungal Infections in the Era of Antifungal Resistance
Kim, U. J., & Jung, S.-I. (2015) · Korean Journal of Medicine · doi:10.3904/kjm.2015.88.5.518 · Cited by 1
Problems related to antifungal prescription: a qualitative study of the views of intensivists
Salci, T. P., Batilana, A. P., Pietrobon, R. S., & Caparroz‐Assef, S. M. (2014) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12181 · Cited by 1
“Antifungal drugs are not beyond the scope of this context because problems related to the use of these medications have been demonstrated [15].”
BackgroundEarly Recognition of Invasive Candidiasis in the ICU
Charles, P., Bruyère, R., & Dalle, F. (2012) · Springer eBooks · doi:10.1007/978-3-642-25716-2_29 · Cited by 2
“Besides the severity of the underlying disease of these patients, the fact that antifungal treatments are frequently delayed is probably one of the main causes of treatment failure [9].”
BackgroundRisk Factors for Mortality in Patients with Candidemia and the Usefulness of a Candida Score
Moon, I. K., Yu, S., 위지완, 추은주, Park, S. Y., 이은정, Park, S. Y., 강효철, & 김태형 (2013) · Journal of Mycology and Infection · doi:10.17966/jmi.2013.18.3.59 · Cited by 1
L’albumine endogène : un pouvoir anti-oxydant majeur
Mira, J. P. (2008) · Réanimation · doi:10.1016/s1624-0693(08)73934-3 · Cited by 4
Antifungal therapy: current concepts and evidence-based management
Perfect, J. R., & Andes, D. R. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761136 · Cited by 1
Particularidades clínicas del paciente crítico con infección fúngica invasora
Borges-Sa, M., & Aranda-Pérez, M. (2012) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.03.008 · Cited by 3
Future Diagnostic and Therapeutic Approaches in Surgical Infections
Haas, B., & Nathens, A. B. (2009) · Surgical Clinics of North America · doi:10.1016/j.suc.2008.09.013 · Cited by 1
Molina, J. R., Rojas, R., Serrano, J., & Gómez, P. (2012) · Journal of Hematological Malignancies · doi:10.5430/jhm.v2n4p1 · Cited by 1
“We have considered that one of the main points is the restoration of the host immune response, particularly in our experience granulocyte recovery [72] joined to an early and appropriate treatment ([73]).”
BackgroundRole of Antimicrobial Prophylaxis During Treatment of Adults with Acute Leukemia
Cohen, N., & Seo, S. K. (2015) · International Journal of Hematologic Oncology · doi:10.2217/ijh.15.7 · Cited by 1
Intensive Care Units: at the Frontline of Infectious Disease
Montravers, P., & Lyon, S. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0201-2 · Cited by 1
Candida-Antigen-Titer (CAG-Titer) for Detection and Early Treatment of Impending Candidemia
Jachec, S., Perbix, W., Lefering, R. L., Díaz, C. A. R., Spilker, G., & Wein, C. (2015) · Research and reviews : journal of medical and health sciences/Research an reviews : journal of medical and health sciences · Cited by 1
Zingg, W., Eggimann, P., & Pittet, D. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1367-1.00132-4 · Cited by 2
Probiotics in Invasive Candidiasis
Colombo, J., & Arena, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802189-7.00048-4 · Cited by 2
Ferrer, R., Zaragoza, R., Llinares, P., Maseda, E., Rodríguez, A. H., & Quindós, G. (2016) · Medicina Intensiva (English Edition) · doi:10.1016/j.medin.2016.07.003 · Cited by 2
The Role of Biomarkers for Starting Antifungals in the Intensive Care Unit
Pagani, J., Revelly, J., Que, Y., & Eggimann, P. (2015) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000118 · Cited by 1
“Early empirical antifungal treatment has been repeatedly demonstrated to improve the prognosis and it has been generalized progressively to almost all critically ill patients with Candida colonization who are perceived to be at risk of invasive candidiasis development.(11,12) Unfortunately, these practices have led to…”
BackgroundNew Molecular Method for Detection of Candidemia, but Don’t Forget the Blood Cultures
Hawley, H. B. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1101 · Cited by 1
Infections in Hematopoietic Stem Cell Transplant Recipients
Almyroudis, N. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-77674-3_11 · Cited by 1
Antifungal Treatments in Critically Ill Patients
Poli, M., Trevisan, G., Girolamo, L. D., & Spinelli, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-94189-9_14 · Cited by 1
Candida Infections in Hematopoietic and Solid Organ Transplant Recipients
Freifeld, A. G., & Kauffman, C. A. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9034-4_32 · Cited by 1
Imaging Fungal Infections and Therapy Follow-Up
Glaudemans, A. W. J. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-25494-0_16 · Cited by 1
Belotserkovskiy, B. Z., Гельфанд, Е. Б., Bykov, A. O., Mamontova, O. A., & Николаевич, П. Д. (2019) · Surgery and Oncology · doi:10.17650/2686-9594-2019-9-4-11-20 · Cited by 1
Spezielle nosokomiale Infektionen auf der Intensivstation
(2012) · Elsevier eBooks · doi:10.1016/b978-3-437-23135-3.10007-8 · Cited by 1
Er, H., Özyurt, Ö. K., Özhak, B., Yazısız, H., Öngüt, G., Sarıtaş, Z. E., Dönmez, L., Çolak, D., Günseren, F., & Öğünç, D. (2020) · Mikrobiyoloji Bulteni · doi:10.5578/mb.69832 · Cited by 1
Das, S. K., Tawde, Y., Singh, S., Chakrabarti, A., Ray, P., Rudramurthy, S. M., Kaur, H., & Ghosh, A. K. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0077 · Cited by 1
Kutsevalova, O. Y., Kozel, Y. Y., Nifantiev, N. E., Antonets, A. V., & Krylov, V. B. (2021) · South Russian Journal of Cancer · doi:10.37748/2686-9039-2021-2-3-5 · Cited by 1
“Фактически, 1-2 дня задержки начала эффективной противогрибковой терапии удваивает риск смерти от ИК [13, 14].”
Metadata
- Authors
- Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T.
- Affiliations
- University of Houston (US)
- University of New Mexico (US)
- Baptist Memorial Health Care (US)
- University of Tennessee Health Science Center (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Oregon State University (US)
- Corresponding author
- Garey, Kevin W.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07
- Volume
- 43
- Issue
- 1
- Pages
- 25-31
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2164001967
- Semantic Scholar
- e1a67fd5e540307550577ea7a071370b075e943f
- Cited by
- 1,171
- References
- 20
- Citations by year
- 2026: 31 · 2025: 26 · 2024: 31 · 2023: 31 · 2022: 49 · 2021: 67 · 2020: 51 · 2019: 51 · 2018: 62 · 2017: 66 · 2016: 61 · 2015: 74 · 2014: 87 · 2013: 83 · 2012: 77
- FWCI
- 35.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Enzon Pharmaceuticals
- University of Houston
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, fluconazole, treatment delay, mortality, fungemia, Candida albicans, APACHE II score, mortality risk factors, hospitalized patients, Candida tropicalis, Candida parapsilosis, Candida glabrata, diabetes mellitus, cancer patients, sepsis
- MeSH terms
- Adult, Aged, Antifungal Agents, Candidiasis, Female, Humans, Length of Stay, Male, Middle Aged, Retrospective Studies, Time Factors, Cohort Studies, Fluconazole, Fungemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.